Interim report January 1 - March 31, 2023
FIRST QUARTER (JANUARY – MARCH 2023) · Order intake SEK 206.6 M (272.5) · Net sales SEK 230.2 M (208.1) · Operating profit SEK 23.7 M (29.6) · Profit after tax SEK 17.6 M (19.3) · Earnings per share before/after dilution SEK 0.51 (0.56) · Cash flow SEK 84.5 M (35.3) · Order backlog SEK 1,903.3 M (1,488.7) at the end of the period SIGNIFICANT EVENTS DURING THE FIRST QUARTER · In January, RaySearch announced that the number of radiotherapy clinics in Japan using RayStation for dose planning has now passed 200. Japan is RaySearch's second largest market in terms